|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00954 CHANGMAO BIO
Nominal 
0.247 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 289,547 | 6.342% | 556,925 | 584,794 | 637,078 | 730,034 |
| Cost of Sales | (247,006) | -4.678% | (539,092) | (568,017) | (611,269) | (549,203) |
| Gross Profit | 42,541 | 223.481% | 17,833 | 16,777 | 25,809 | 180,831 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 145 | -- | 41 | (205) | (183) | 136 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (3,146) | -87.535% | (64,963) | (67,582) | (58,580) | 87,644 | |
| Taxation | (1,947) | 160.294% | (2,207) | (669) | (27,938) | (6,286) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 161 | -18.274% | 407 | 8 | 461 | 65 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (4,932) | -80.876% | (66,763) | (68,243) | (86,057) | 81,423 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,154 | 59.089% | 16,593 | 10,514 | 6,532 | 1,729 |
| Depreciation & Amortisation | 28,251 | 14.169% | 54,204 | 45,616 | 42,745 | 32,202 |
| Directors' Emoluments | -- | -- | 2,390 | 1,987 | 1,979 | 6,615 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -0.900 | -81.633% | -12.600 | -12.900 | -16.200 | 15.400 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 7.700 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | 50.000% |
| Cash flow per share ($) | -- | -- | 0.037 | (0.061) | (0.004) | 0.037 |
| NBV per share ($) | 0.966 | -- | 0.975 | 1.101 | 1.230 | 1.470 |
| Remarks: | Real time quote last updated: 20/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -4,932 |
| %Change | -80.876% |
| EPS / (LPS) | RMB -0.009 |
| NBV Per Share (¥) | RMB 0.966 |